CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 1 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,055,641 | -22.1% | 277,400 | +13.5% | 0.07% | -26.9% |
| Q2 2023 | $7,772,654 | +31.8% | 244,500 | +1.1% | 0.09% | +34.8% |
| Q1 2023 | $5,897,502 | -5.2% | 241,800 | +22.6% | 0.07% | +6.2% |
| Q4 2022 | $6,219,686 | +62.3% | 197,200 | +45.4% | 0.06% | +58.5% |
| Q3 2022 | $3,832,000 | +1124.3% | 135,600 | +1006.7% | 0.04% | +1950.0% |
| Q2 2021 | $313,000 | +160.8% | 12,253 | +39.6% | 0.00% | +100.0% |
| Q1 2021 | $120,000 | – | 8,776 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |